Form 4: Tenet Healthcare Director Nadja West Reports Routine Stock Transactions and New Equity Grant

Tenet Healthcare Director Nadja West reported the settlement of restricted stock units, the sale of common stock, and the grant of new restricted stock units in recent transactions.

Summary

• Nadja West, a Director of Tenet Healthcare Corp (THC), reported multiple equity transactions.
• On May 23, 2025, she acquired 1,551 shares of THC common stock through the settlement of previously granted restricted stock units (RSUs).
• Concurrently, she disposed of 573 shares of THC common stock at a price of $161.33 per share.
• Following these transactions, her direct beneficial ownership of common stock in Tenet Healthcare Corp decreased from 31,231 shares to 30,658 shares.
• Additionally, on May 22, 2025, Ms. West was granted 1,333 new restricted stock units under the Company's Stock Incentive Plan.
• The previously settled 1,551 RSUs were converted with 37% settled in cash and 63% in shares.
• The newly granted 1,333 RSUs are scheduled to vest on May 22, 2026, and also offer the option for up to 37% cash settlement.

Sentiment

Score: 5

Explanation: The document reports routine insider transactions, including both the grant of new equity awards and the sale of a portion of existing shares, which is common for executive compensation and tax planning. There is no indication of significant positive or negative news for the company's operations or financial health.

Positives

• Grant of 1,333 new Restricted Stock Units to Director Nadja West, aligning her interests with long-term company performance.
• The new RSUs vest on the first anniversary of the grant date (May 22, 2026), providing a clear future incentive.

Negatives

• Disposition of 573 shares of common stock by a director, which slightly reduces direct beneficial ownership.
• A net decrease in direct common stock ownership from 31,231 shares to 30,658 shares after the reported transactions.

Future Outlook

The newly granted 1,333 restricted stock units are scheduled to vest on May 22, 2026, indicating a future equity event for the reporting person.

Industry Context

This Form 4 filing details routine insider equity transactions for a director of Tenet Healthcare Corp, a major healthcare services provider. Such filings are standard disclosures required by the SEC for public companies and their insiders, reflecting individual compensation and investment decisions rather than broader industry trends.

Stakeholder Impact

• Minimal impact on shareholders as the reported transactions are routine insider equity movements, including compensation grants and a small sale of shares.
• The grant of new restricted stock units aligns the director's interests with long-term shareholder value.

Next Steps

• Vesting of 1,333 Restricted Stock Units on May 22, 2026.

Key Dates

Keywords

Tenet Healthcare, THC, Nadja West, Form 4, Insider Trading, Stock Transactions, Restricted Stock Units, Director, Share Sale, Equity Compensation